Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE9.1500
- TODAY'S CHANGE (%)0.0900 (0.9934%)
- Bid / Lots7.2500/ 1
- Ask / Lots9.5200/ 1
- Open / Previous Close8.9400 / 9.0600
- Day Range
- 52 Week Range
- Volume677,291
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 5383 | 8.9 |
| 09:34 ET | 1800 | 8.915 |
| 09:38 ET | 100 | 8.905 |
| 09:39 ET | 300 | 8.89 |
| 09:41 ET | 400 | 8.96 |
| 09:43 ET | 3132 | 9.01 |
| 09:45 ET | 100 | 8.96 |
| 09:48 ET | 5893 | 9.02 |
| 09:50 ET | 3080 | 9.04 |
| 09:52 ET | 2650 | 9.06 |
| 09:54 ET | 2100 | 9.08 |
| 09:56 ET | 1100 | 9.14 |
| 09:57 ET | 600 | 9.19 |
| 09:59 ET | 400 | 9.25 |
| 10:01 ET | 300 | 9.21 |
| 10:03 ET | 15370 | 9.235 |
| 10:06 ET | 1500 | 9.24 |
| 10:08 ET | 2538 | 9.235 |
| 10:10 ET | 5356 | 9.2 |
| 10:12 ET | 7806 | 9.31 |
| 10:14 ET | 10545 | 9.24 |
| 10:15 ET | 1100 | 9.215 |
| 10:17 ET | 1900 | 9.195 |
| 10:19 ET | 100 | 9.1764 |
| 10:21 ET | 100 | 9.185 |
| 10:24 ET | 2740 | 9.16 |
| 10:26 ET | 1500 | 9.11 |
| 10:28 ET | 400 | 9.12 |
| 10:30 ET | 2166 | 9.185 |
| 10:32 ET | 1300 | 9.17 |
| 10:33 ET | 400 | 9.175 |
| 10:35 ET | 200 | 9.175 |
| 10:37 ET | 800 | 9.2 |
| 10:39 ET | 1400 | 9.185 |
| 10:42 ET | 1900 | 9.16 |
| 10:44 ET | 4257 | 9.11 |
| 10:46 ET | 1000 | 9.075 |
| 10:48 ET | 700 | 9.08 |
| 10:50 ET | 700 | 9.06 |
| 10:53 ET | 3400 | 9.015 |
| 10:55 ET | 107 | 9.03 |
| 10:57 ET | 500 | 9.015 |
| 11:00 ET | 200 | 9.02 |
| 11:02 ET | 300 | 9.025 |
| 11:04 ET | 400 | 9.035 |
| 11:06 ET | 500 | 9.05 |
| 11:08 ET | 850 | 9.035 |
| 11:09 ET | 400 | 9.05 |
| 11:11 ET | 3279 | 9 |
| 11:13 ET | 940 | 8.98 |
| 11:15 ET | 4604 | 8.995 |
| 11:18 ET | 2044 | 8.99 |
| 11:20 ET | 3586 | 8.96 |
| 11:22 ET | 6581 | 8.9 |
| 11:24 ET | 5182 | 8.965 |
| 11:26 ET | 700 | 8.95 |
| 11:27 ET | 1250 | 8.99 |
| 11:29 ET | 100 | 8.98 |
| 11:31 ET | 400 | 9 |
| 11:33 ET | 3300 | 9 |
| 11:36 ET | 3750 | 8.92 |
| 11:38 ET | 300 | 8.935 |
| 11:40 ET | 200 | 8.935 |
| 11:42 ET | 2759 | 8.99 |
| 11:44 ET | 25239 | 9.07 |
| 11:45 ET | 1550 | 9.07 |
| 11:47 ET | 3741 | 9.08 |
| 11:49 ET | 6762 | 9.11 |
| 11:51 ET | 1300 | 9.13 |
| 11:54 ET | 631 | 9.13 |
| 11:56 ET | 600 | 9.135 |
| 11:58 ET | 3880 | 9.16 |
| 12:00 ET | 300 | 9.154 |
| 12:03 ET | 2601 | 9.16 |
| 12:05 ET | 2744 | 9.18 |
| 12:07 ET | 600 | 9.16 |
| 12:09 ET | 1364 | 9.17 |
| 12:12 ET | 600 | 9.17 |
| 12:14 ET | 1520 | 9.17 |
| 12:16 ET | 4032 | 9.135 |
| 12:18 ET | 900 | 9.135 |
| 12:20 ET | 100 | 9.14 |
| 12:21 ET | 300 | 9.145 |
| 12:23 ET | 894 | 9.15 |
| 12:25 ET | 100 | 9.15 |
| 12:27 ET | 200 | 9.15 |
| 12:30 ET | 400 | 9.15 |
| 12:32 ET | 2190 | 9.16 |
| 12:34 ET | 500 | 9.16 |
| 12:36 ET | 300 | 9.16 |
| 12:38 ET | 500 | 9.17 |
| 12:39 ET | 300 | 9.16 |
| 12:41 ET | 1752 | 9.17 |
| 12:43 ET | 300 | 9.17 |
| 12:45 ET | 600 | 9.18 |
| 12:48 ET | 367 | 9.17 |
| 12:50 ET | 800 | 9.17 |
| 12:52 ET | 2500 | 9.15 |
| 12:54 ET | 300 | 9.15 |
| 12:56 ET | 1200 | 9.15 |
| 12:57 ET | 500 | 9.15 |
| 12:59 ET | 6890 | 9.07 |
| 01:01 ET | 4889 | 9.04 |
| 01:03 ET | 750 | 9.03 |
| 01:06 ET | 1400 | 9.04 |
| 01:08 ET | 1200 | 9.025 |
| 01:10 ET | 605 | 9.01 |
| 01:12 ET | 100 | 9.02 |
| 01:14 ET | 1700 | 9.03 |
| 01:15 ET | 5264 | 9.015 |
| 01:17 ET | 14910 | 9.025 |
| 01:19 ET | 55687 | 8.96 |
| 01:21 ET | 9126 | 8.99 |
| 01:24 ET | 3600 | 8.99 |
| 01:26 ET | 500 | 8.99 |
| 01:28 ET | 100 | 9 |
| 01:30 ET | 3216 | 9 |
| 01:32 ET | 1600 | 8.98 |
| 01:33 ET | 648 | 8.96 |
| 01:35 ET | 100 | 8.96 |
| 01:39 ET | 1085 | 9 |
| 01:42 ET | 100 | 9.01 |
| 01:44 ET | 6982 | 9.08 |
| 01:46 ET | 500 | 9.1 |
| 01:48 ET | 1533 | 9.09 |
| 01:50 ET | 1100 | 9.1 |
| 01:51 ET | 1100 | 9.1 |
| 01:53 ET | 200 | 9.1 |
| 01:55 ET | 300 | 9.1 |
| 02:00 ET | 795 | 9.1 |
| 02:02 ET | 600 | 9.1 |
| 02:04 ET | 670 | 9.1 |
| 02:06 ET | 5064 | 9.05 |
| 02:08 ET | 500 | 9.07 |
| 02:11 ET | 400 | 9.09 |
| 02:13 ET | 8983 | 9.1 |
| 02:15 ET | 400 | 9.105 |
| 02:18 ET | 5970 | 9.09 |
| 02:20 ET | 3750 | 9.065 |
| 02:22 ET | 200 | 9.08 |
| 02:24 ET | 700 | 9.065 |
| 02:26 ET | 200 | 9.08 |
| 02:27 ET | 2200 | 9.08 |
| 02:29 ET | 700 | 9.06 |
| 02:31 ET | 20101 | 9.26 |
| 02:33 ET | 3337 | 9.275 |
| 02:36 ET | 8921 | 9.22 |
| 02:38 ET | 300 | 9.225 |
| 02:40 ET | 3192 | 9.195 |
| 02:42 ET | 9778 | 9.14 |
| 02:45 ET | 650 | 9.22 |
| 02:47 ET | 300 | 9.24 |
| 02:49 ET | 400 | 9.26 |
| 02:51 ET | 3667 | 9.255 |
| 02:54 ET | 4233 | 9.19 |
| 02:56 ET | 1821 | 9.2172 |
| 02:58 ET | 1210 | 9.195 |
| 03:00 ET | 300 | 9.18 |
| 03:02 ET | 100 | 9.18 |
| 03:03 ET | 540 | 9.17 |
| 03:05 ET | 2635 | 9.21 |
| 03:07 ET | 2006 | 9.2 |
| 03:09 ET | 100 | 9.2 |
| 03:12 ET | 207 | 9.2 |
| 03:14 ET | 919 | 9.21 |
| 03:16 ET | 300 | 9.22 |
| 03:18 ET | 2697 | 9.205 |
| 03:20 ET | 580 | 9.22 |
| 03:21 ET | 800 | 9.23 |
| 03:23 ET | 1325 | 9.23 |
| 03:25 ET | 307 | 9.22 |
| 03:27 ET | 542 | 9.22 |
| 03:30 ET | 3665 | 9.2 |
| 03:32 ET | 1200 | 9.16 |
| 03:34 ET | 3073 | 9.17 |
| 03:36 ET | 1300 | 9.19 |
| 03:38 ET | 1400 | 9.2 |
| 03:39 ET | 873 | 9.22 |
| 03:41 ET | 9139 | 9.12 |
| 03:43 ET | 4592 | 9.12 |
| 03:45 ET | 3377 | 9.15 |
| 03:48 ET | 3021 | 9.16 |
| 03:50 ET | 1310 | 9.16 |
| 03:52 ET | 9288 | 9.13 |
| 03:54 ET | 2513 | 9.13 |
| 03:56 ET | 6062 | 9.17 |
| 03:57 ET | 3086 | 9.17 |
| 03:59 ET | 75858 | 9.15 |
Apr 15, 2024
DJ Neumora Shares Slide Premarket as FDA Puts Early Study of Schizophrenia Drug on Hold, from 7:05AM ET on Monday Apr 15, 2024 by Dow Jones
7:05AM ET on Monday Apr 15, 2024 by Dow JonesNeumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study, from 6:30AM ET on Monday Apr 15, 2024 by Dow Jones
6:30AM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 1.5B | -3.9x | --- |
Gyre Therapeutics Inc | 1.5B | -0.8x | --- |
Kura Oncology Inc | 1.5B | -9.4x | --- |
Edgewise Therapeutics Inc | 1.5B | -10.3x | --- |
Morphic Holding Inc | 1.4B | -8.0x | --- |
Akero Therapeutics Inc | 1.4B | -6.9x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way,, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Technology Operatings Officer
- Raj Manchanda
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 158.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.33 |
Book Value | $2.95 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
